Annovis Bio, Inc.
NYSE:ANVS
4.37 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Assets: | |||||||
Current Assets: | |||||||
Cash & Cash Equivalents
| 5.755 | 28.378 | 45.686 | 8.075 | 0.002 | 0.035 | 0.347 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 5.755 | 28.378 | 45.686 | 8.075 | 0.002 | 0.035 | 0.347 |
Net Receivables
| 0 | 0 | 0 | 0 | 0.735 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | -745.643 | 0 | 0 |
Other Current Assets
| 4.454 | 0.105 | 0.073 | 0.038 | 0.004 | 0.012 | 0.007 |
Total Current Assets
| 10.208 | 36.022 | 46.001 | 8.119 | 0.748 | 0.051 | 0.358 |
Non-Current Assets: | |||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0 | 0 | 0 | 0.37 | 0 | 0 |
Total Non-Current Assets
| 0 | 0 | 0 | 0 | 0.37 | 0 | 0 |
Total Assets
| 10.208 | 36.022 | 46.001 | 8.119 | 1.117 | 0.051 | 0.358 |
Liabilities & Equity: | |||||||
Current Liabilities: | |||||||
Account Payables
| 1.293 | 3.961 | 0.688 | 0.342 | 1.234 | 0.068 | 0.071 |
Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 2.986 | 3.737 | 0.818 | 0.237 | 0.777 | 0.5 | 0.419 |
Total Current Liabilities
| 4.279 | 7.699 | 1.507 | 0.578 | 2.011 | 0.568 | 0.49 |
Non-Current Liabilities: | |||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0.5 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 13.68 | 0 | 0 | 0 | 7.183 | 7.077 | 6.833 |
Total Non-Current Liabilities
| 13.68 | 3.961 | 0 | 0 | 7.683 | 7.077 | 6.833 |
Total Liabilities
| 17.959 | 7.699 | 1.507 | 0.578 | 9.694 | 7.645 | 7.324 |
Equity: | |||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 7.077 | 7.077 | 6.833 |
Common Stock
| 0.001 | 0.001 | 0.001 | 0.001 | 0 | 0 | 0 |
Retained Earnings
| -110.259 | -54.055 | -28.726 | -14.239 | -8.777 | -7.786 | -7.072 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | -0 | -7.077 | -7.077 | -6.833 |
Other Total Stockholders Equity
| 102.507 | 82.377 | 73.22 | 21.779 | 0.201 | 14.154 | 13.667 |
Total Shareholders Equity
| -7.751 | 28.324 | 44.495 | 7.541 | -8.576 | -7.594 | -6.966 |
Total Equity
| -7.751 | 28.324 | 44.495 | 7.541 | -8.576 | -7.594 | -6.966 |
Total Liabilities & Shareholders Equity
| 10.208 | 36.022 | 46.001 | 8.119 | 1.117 | 0.051 | 0.358 |